A New Clinically Applicable Measure of Functional Status in Patients With Heart Failure: The 60-Foot Walk Test
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Date
2017Journal
JACC: Heart FailurePublisher
Elsevier Inc.Type
Article
Metadata
Show full item recordAbstract
Objectives This study reports the development and predictive value of the 60-foot walk test (60ftWT), a brief functional status measure for patients with heart failure (HF). The goal was to develop a test suitable for clinical settings and appropriate for patients with walking impairments. Background The 6-min walk test (6MWT) has considerable predictive value, but requires a long walking course and has limited utility in patients with mobility-related comorbidities. A shorter, more clinically practical test is therefore needed. Methods A total of 144 patients (age 57.4 ± 11.4 years; 111 males) with symptomatic HF received baseline assessments using the 60ftWT, 6MWT, and self-reported symptom and health status. Patients were tested 3 months later to determine stability of assessments. HF hospitalizations or death from any cause were recorded for 3.5 years following baseline. Results Median 60ftWT completion time was 26 s (interquartile range: 22 to 31 s). Longer 60ftWT time was associated with shorter 6MWT distance (r = −0.75; p < 0.001), and with higher symptom severity at baseline (r = −0.40; p < 0.001). Longer 60ftWT times also predicted increases in 6MWT and symptoms from baseline to 3 months (p < 0.01). Both WTs predicted long-term clinical outcomes, with patients taking longer than 31 s to complete the 60ftWT at greatest risk for HF hospitalization or death (hazard ratio: 2.13; 95% confidence interval: 1.18 to 3.84; p = 0.01). Conclusions The 60ftWT is an easily administered functional status measure that predicts adverse events, symptoms, and health status. It has the potential for considerable clinical utility to help identify patients at risk for future events and to calibrate treatments designed to improve functional status and quality of life. Copyright 2017Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019155432&doi=10.1016%2fj.jchf.2017.02.005&partnerID=40&md5=cdba843db7dca24ccfd6d99c2aa27dcc; http://hdl.handle.net/10713/10036ae974a485f413a2113503eed53cd6c53
10.1016/j.jchf.2017.02.005
Scopus Count
Collections
Related articles
- Prognostic value of serial six-minute walk tests using tele-accelerometry in patients with chronic heart failure: A pre-specified sub-study of the TIM-HF-Trial.
- Authors: Prescher S, Schoebel C, Koehler K, Deckwart O, Wellge B, Honold M, Hartmann O, Winkler S, Koehler F
- Issue date: 2016 Oct
- Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study.
- Authors: Ferreira JP, Metra M, Anker SD, Dickstein K, Lang CC, Ng L, Samani NJ, Cleland JG, van Veldhuisen DJ, Voors AA, Zannad F
- Issue date: 2019 Feb
- Utility of Walk Tests in Evaluating Functional Status Among Participants in an Outpatient Cardiac Rehabilitation Program.
- Authors: Harris KM, Anderson DR, Landers JD, Emery CF
- Issue date: 2017 Sep
- Prediction of 6-minute walk performance in patients with peripheral artery disease.
- Authors: Chen X, Stoner JA, Montgomery PS, Casanegra AI, Silva-Palacios F, Chen S, Janitz AE, Gardner AW
- Issue date: 2017 Oct
- Association between the 6-minute walk test and exercise confidence in patients with heart failure: A prospective observational study.
- Authors: Ha FJ, Toukhsati SR, Cameron JD, Yates R, Hare DL
- Issue date: 2018 Jan - Feb